Insider · CIK 0001213040

Carter Martha J.

Reports to the SEC for 2 companies · MORRISTOWN, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001213040

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-03-02	ALBIREO PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Chief Regulatory Officer	DDisposition to Issuer	−15.9K sh	—	—	0
2023-03-02	ALBIREO PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Chief Regulatory Officer	DDisposition to Issuer	−23.7K sh	—	—	0
2023-03-02	ALBIREO PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Chief Regulatory Officer	DDisposition to Issuer	−3,250 sh	—	—	0
2023-03-02	ALBIREO PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Chief Regulatory Officer	DDisposition to Issuer	−62K sh	—	—	0
2023-03-02	ALBIREO PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Chief Regulatory Officer	DDisposition to Issuer	−2,500 sh	—	—	0
2023-03-02	ALBIREO PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Chief Regulatory Officer	DDisposition to Issuer	−19.7K sh	—	—	0
2023-03-02	ALBIREO PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Chief Regulatory Officer	DDisposition to Issuer	−31.5K sh	—	—	0
2023-03-02	ALBIREO PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Chief Regulatory Officer	DDisposition to Issuer	−30K sh	—	—	0
2023-03-02	ALBIREO PHARMA, INC.Restricted Stock UnitsD Disposition to Issuer	Chief Regulatory Officer	DDisposition to Issuer	−65.9K sh	—	—	0
2023-03-02	ALBIREO PHARMA, INC.U Disposition from Tender	Chief Regulatory Officer	UDisposition from Tender	−3,656 sh	—	—	3,654
2023-01-23	ALBIREO PHARMA, INC.S Sale	Chief Regulatory Officer	SSale	−120 sh	$43.80	−$5,256	14,506
2023-01-19	ALBIREO PHARMA, INC.S Sale	Chief Regulatory Officer	SSale	−938 sh	$43.90	−$41.2K	14,626
2023-01-19	ALBIREO PHARMA, INC.A Award	Chief Regulatory Officer	AAward	+55K sh	—	—	69,506
2023-01-19	ALBIREO PHARMA, INC.A Award	Chief Regulatory Officer	AAward	+55K sh	—	—	69,506
2022-10-24	ALBIREO PHARMA, INC.S Sale	Chief Regulatory Officer	SSale	−104 sh	$19.58	−$2,035.946	15,564
2022-07-22	ALBIREO PHARMA, INC.S Sale	Chief Regulatory Officer	SSale	−106 sh	$24.68	−$2,615.794	15,668
2022-04-22	ALBIREO PHARMA, INC.S Sale	Chief Regulatory Officer	SSale	−103 sh	$32.92	−$3,391.244	15,774
2022-01-24	ALBIREO PHARMA, INC.S Sale	Chief Regulatory Officer	SSale	−423 sh	$24.52	−$10.4K	15,877
2022-01-18	ALBIREO PHARMA, INC.Stock Option (right to buy)A Award	Chief Regulatory Officer	AAward	+15.9K sh	—	—	15,900
2022-01-18	ALBIREO PHARMA, INC.A Award	Chief Regulatory Officer	AAward	+10.8K sh	—	—	16,300
2021-01-21	ALBIREO PHARMA, INC.A Award	Chief Regulatory Officer	AAward	+5,500 sh	—	—	5,500
2021-01-21	ALBIREO PHARMA, INC.Stock Option (right to buy)A Award	Chief Regulatory Officer	AAward	+23.7K sh	—	—	23,700
2020-09-11	ALBIREO PHARMA, INC.S Sale	Chief Regulatory Officer	SSale	−10K sh	$40.03	−$400K	0
2020-09-11	ALBIREO PHARMA, INC.M Exercise/Conversion	Chief Regulatory Officer	MExercise/Conversion	+9,062 sh	$24.48	+$222K	9,062
2020-09-11	ALBIREO PHARMA, INC.Stock Option (right to buy)M Exercise/Conversion	Chief Regulatory Officer	MExercise/Conversion	−938 sh	—	—	62,009
2020-09-11	ALBIREO PHARMA, INC.Stock Option (right to buy)M Exercise/Conversion	Chief Regulatory Officer	MExercise/Conversion	−9,062 sh	—	—	3,250
2020-09-11	ALBIREO PHARMA, INC.M Exercise/Conversion	Chief Regulatory Officer	MExercise/Conversion	+938 sh	$29.76	+$27.9K	10,000
2020-09-10	ALBIREO PHARMA, INC.Stock Option (right to buy)M Exercise/Conversion	Chief Regulatory Officer	MExercise/Conversion	−9,312 sh	—	—	19,688
2020-09-10	ALBIREO PHARMA, INC.M Exercise/Conversion	Chief Regulatory Officer	MExercise/Conversion	+9,312 sh	$24.04	+$224K	9,312
2020-09-10	ALBIREO PHARMA, INC.M Exercise/Conversion	Chief Regulatory Officer	MExercise/Conversion	+688 sh	$24.48	+$16.8K	10,000
2020-09-10	ALBIREO PHARMA, INC.S Sale	Chief Regulatory Officer	SSale	−10K sh	$42.41	−$424K	0
2020-09-10	ALBIREO PHARMA, INC.Stock Option (right to buy)M Exercise/Conversion	Chief Regulatory Officer	MExercise/Conversion	−688 sh	—	—	12,312
2020-09-09	ALBIREO PHARMA, INC.S Sale	Chief Regulatory Officer	SSale	−7,500 sh	$38.68	−$290K	2,500
2020-09-09	ALBIREO PHARMA, INC.M Exercise/Conversion	Chief Regulatory Officer	MExercise/Conversion	+2,500 sh	$24.04	+$60.1K	10,000
2020-09-09	ALBIREO PHARMA, INC.Stock Option (right to buy)M Exercise/Conversion	Chief Regulatory Officer	MExercise/Conversion	−7,500 sh	—	—	2,500
2020-09-09	ALBIREO PHARMA, INC.M Exercise/Conversion	Chief Regulatory Officer	MExercise/Conversion	+7,500 sh	$19.19	+$144K	7,500
2020-09-09	ALBIREO PHARMA, INC.Stock Option (right to buy)M Exercise/Conversion	Chief Regulatory Officer	MExercise/Conversion	−2,500 sh	—	—	29,000
2020-09-09	ALBIREO PHARMA, INC.S Sale	Chief Regulatory Officer	SSale	−2,500 sh	$39.82	−$99.6K	0
2020-09-08	ALBIREO PHARMA, INC.M Exercise/Conversion	Chief Regulatory Officer	MExercise/Conversion	+10K sh	$19.19	+$192K	10,000
2020-09-08	ALBIREO PHARMA, INC.Stock Option (right to buy)M Exercise/Conversion	Chief Regulatory Officer	MExercise/Conversion	−10K sh	—	—	10,000
2020-09-08	ALBIREO PHARMA, INC.S Sale	Chief Regulatory Officer	SSale	−10K sh	$45.55	−$456K	0
2020-01-21	ALBIREO PHARMA, INC.Stock Option (right to buy)A Award	Chief Regulatory Officer	AAward	+31.5K sh	—	—	31,500
2019-01-22	ALBIREO PHARMA, INC.Stock Option (right to buy)A Award	Chief Regulatory Officer	AAward	+31.5K sh	—	—	31,500
2018-06-08	ALBIREO PHARMA, INC.Stock Option (right to buy)A Award	Chief Regulatory Officer	AAward	+30K sh	—	—	30,000
2017-08-21	ALBIREO PHARMA, INC.Stock Option (right to buy)A Award	Chief Regulatory Officer	AAward	+13K sh	—	—	13,000
2017-01-20	ALBIREO PHARMA, INC.Stock Option (right to buy)A Award	Chief Regulatory Officer	AAward	+20K sh	—	—	20,000
2016-11-28	ALBIREO PHARMA, INC.Stock Option (right to buy)A Award	Chief Regulatory Officer	AAward	+62.9K sh	—	—	62,947
2016-05-09	Aegerion Pharmaceuticals, Inc.Restricted Stock UnitsA Award	See Remarks	AAward	+13K sh	—	—	13,000
2016-05-09	Aegerion Pharmaceuticals, Inc.Stock Option (right to buy)A Award	See Remarks	AAward	+26K sh	—	—	26,000
2015-08-04	Aegerion Pharmaceuticals, Inc.Stock Option (right to buy)A Award	See Remarks	AAward	+40K sh	—	—	40,000

Recent filings

Accepted (ET)
Mar 24
Carter Martha J.0001209191-23-014753
SEC(opens sec.gov)
Jan 274/A
Carter Martha J.0001209191-23-005336
SEC(opens sec.gov)
Jan 254
Carter Martha J.0001209191-23-004951
SEC(opens sec.gov)
Jan 234
Carter Martha J.0001209191-23-004438
SEC(opens sec.gov)
Jan 204
Carter Martha J.0001209191-23-004224
SEC(opens sec.gov)
Oct 254
Carter Martha J.0001209191-22-054486
SEC(opens sec.gov)
Jul 254
Carter Martha J.0001209191-22-043110
SEC(opens sec.gov)
Apr 254
Carter Martha J.0001209191-22-025529
SEC(opens sec.gov)
Jan 254
Carter Martha J.0001209191-22-004799
SEC(opens sec.gov)
Jan 204
Carter Martha J.0001209191-22-004067
SEC(opens sec.gov)

Companies

Address

C/O AEGERION PHARMACEUTICALS, INC. 89 HEADQUARTERS PLAZA, STE. 1212

MORRISTOWN, NJ, 07960